IE35910B1 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
IE35910B1
IE35910B1 IE1610/71A IE161071A IE35910B1 IE 35910 B1 IE35910 B1 IE 35910B1 IE 1610/71 A IE1610/71 A IE 1610/71A IE 161071 A IE161071 A IE 161071A IE 35910 B1 IE35910 B1 IE 35910B1
Authority
IE
Ireland
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IE1610/71A
Other languages
English (en)
Other versions
IE35910L (en
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of IE35910L publication Critical patent/IE35910L/xx
Publication of IE35910B1 publication Critical patent/IE35910B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE1610/71A 1971-01-26 1971-12-20 Pharmaceutical composition IE35910B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10994271A 1971-01-26 1971-01-26

Publications (2)

Publication Number Publication Date
IE35910L IE35910L (en) 1972-07-26
IE35910B1 true IE35910B1 (en) 1976-06-23

Family

ID=22330411

Family Applications (2)

Application Number Title Priority Date Filing Date
IE1611/71A IE35937B1 (en) 1971-01-26 1971-12-20 Local anaesthetic composition
IE1610/71A IE35910B1 (en) 1971-01-26 1971-12-20 Pharmaceutical composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IE1611/71A IE35937B1 (en) 1971-01-26 1971-12-20 Local anaesthetic composition

Country Status (18)

Country Link
AT (2) AT310939B (es)
AU (1) AU465875B2 (es)
BE (2) BE776768A (es)
BR (2) BR7108428D0 (es)
CA (2) CA986012A (es)
DD (2) DD96400A5 (es)
DE (2) DE2163055A1 (es)
DK (2) DK130389B (es)
ES (2) ES398109A1 (es)
FR (2) FR2123278B1 (es)
GB (1) GB1370904A (es)
HU (2) HU162185B (es)
IE (2) IE35937B1 (es)
LU (1) LU64664A1 (es)
NL (2) NL7117404A (es)
NO (2) NO135892C (es)
SE (2) SE391286B (es)
ZA (2) ZA718327B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition
AU6883798A (en) * 1997-04-02 1998-10-22 Regents Of The University Of California, The Method of anesthesia
AU7389098A (en) 1997-05-16 1998-12-08 Brigham And Women's Hospital Local anesthetic formulations
US9018222B2 (en) 2006-03-27 2015-04-28 Wex Medical Limited Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
NZ710890A (en) 2013-03-15 2016-11-25 Childrens Medical Ct Corp Neosaxitoxin combination formulations for prolonged local anesthesia

Also Published As

Publication number Publication date
BE776768A (fr) 1972-06-16
NO135892C (no) 1978-05-16
BR7108428D0 (pt) 1973-06-14
NL7117401A (es) 1972-07-28
NO135891B (es) 1977-03-14
NO135891C (no) 1978-05-16
ES398108A1 (es) 1975-03-01
FR2123277B1 (es) 1975-06-13
IE35937B1 (en) 1976-07-07
ZA718327B (en) 1972-09-27
FR2123278B1 (es) 1975-08-01
NL7117404A (es) 1972-07-28
ZA718326B (en) 1972-09-27
DE2163055A1 (de) 1972-10-12
IE35937L (en) 1972-07-26
DD96400A5 (es) 1973-03-20
HU162347B (es) 1973-02-28
CA986012A (en) 1976-03-23
FR2123278A1 (es) 1972-09-08
AT310939B (de) 1973-10-25
IE35910L (en) 1972-07-26
BR7108429D0 (pt) 1973-06-14
NO135892B (es) 1977-03-14
AT310938B (de) 1973-10-25
AU3710171A (en) 1973-06-28
SE391127B (sv) 1977-02-07
LU64664A1 (es) 1972-08-23
AU3710071A (en) 1973-06-28
DK130389B (da) 1975-02-17
DK131606B (da) 1975-08-11
DE2163054B2 (de) 1978-06-01
ES398109A1 (es) 1975-03-16
DE2163054C3 (de) 1979-02-01
DK130389C (es) 1975-07-14
FR2123277A1 (es) 1972-09-08
GB1370904A (en) 1974-10-16
DK131606C (da) 1976-01-12
DD96144A5 (es) 1973-03-12
HU162185B (es) 1973-01-29
SE391286B (sv) 1977-02-14
AU465875B2 (en) 1975-10-09
DE2163054A1 (de) 1974-05-02
BE776769A (fr) 1972-06-16
CA983850A (en) 1976-02-17

Similar Documents

Publication Publication Date Title
IE36891L (en) Coronary-dilating composition
AU5119173A (en) Composition
IL39430A0 (en) Slow release pharmaceutical compositions
AU482733B2 (en) Pharmaceutical compositions
ZA727741B (en) Thermofomable compositions
IE35991L (en) Camphor-containing pharmaceutical composition
CY955A (en) Pharmaceutical compositions
GB1393014A (en) Polyurethane-tar compositions
CA974170A (en) Pharmaceutical compositions
GB1370904A (en) Pharmaceutical composition
ZA713877B (en) Pharmaceutical composition
ZA721363B (en) Pharmaceutical composition
GB1367202A (en) Reflex-reflecting compositions
ZA721169B (en) Pharmaceutical preparation
CY755A (en) Therapeutic composition
ZA723908B (en) Desensitizer composition
IL39516A (en) Substituted 4-propoxy-9-fluorenone compounds and pharmaceutical compositions containing them
CA885421A (en) Pharmaceutical composition
CA884857A (en) Pharmaceutical composition
CA879074A (en) Pharmaceutical compositions
CA888688A (en) Pharmaceutical compositions
CA876689A (en) Pharmaceutical compositions
CA881476A (en) Pharmaceutical compositions
CA882088A (en) Pharmaceutical compositions
CA884856A (en) Pharmaceutical compositions